Navigation Links
Sangamo BioSciences Appoints Paul Cleveland to Its Board of Directors and Chair of Audit Committee
Date:11/19/2008

RICHMOND, Calif., Nov. 19 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO), a leader in the research and development of novel zinc finger DNA-binding proteins (ZFPs) for therapeutic gene regulation and modification, announced today the appointment of Paul B. Cleveland, executive vice president, corporate development and chief financial officer of Affymax, Inc., to its board of directors, effective November 19, 2008. Mr. Cleveland will also serve as chair of Sangamo's audit committee.

"We are very pleased to welcome Paul to Sangamo's board," stated Edward Lanphier, Sangamo's president and CEO. "His significant experience and success in biotechnology industry finance and business development will aid us in all aspects of our company's operations, including clinical and commercial development of our ZFP Therapeutic(TM) programs."

Mr. Cleveland has served as executive vice president, corporate development and chief financial officer of Affymax, Inc. since January 2006. In such capacity, he has responsibility for all business development, strategic planning, finance, investor relations and legal functions. He negotiated a worldwide collaboration with Takeda that was honored with the "Allicense 2007 Breakthrough Alliance Award" at the Recombinant Capital Allicense conference. Mr. Cleveland also led preparations for and execution of Affymax's initial public offering of common stock which was characterized as "the strongest biotech offering of 2006" by Business Week. Together these transactions added more than $230 million to Affymax's cash balance in one year.

From 2004 to 2006, Mr. Cleveland served as a managing director at Integrated Finance, Ltd., an investment bank, and from 1996 to 2003 as a managing director and head of west coast mergers and acquisitions at J.P. Morgan Chase and Co. (
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601
2. Sangamo BioSciences Reports Third Quarter 2008 Financial Results
3. Sangamo BioSciences Presents Data at ICAAC Demonstrating In Vivo Protection Against HIV Infection by CCR5-ZFN Therapeutic
4. Sangamo BioSciences Announces Third Quarter Conference Call and Webcast
5. Sangamo BioSciences to Present at Two Upcoming Investor Conferences
6. Sangamo BioSciences to Present at the UBS Global Life Sciences Conference
7. Sangamo BioSciences to Present at the Canaccord Adams Global Growth Conference
8. Sangamo BioSciences to Present at the BMO Capital Markets Focus on Healthcare Conference
9. Sangamo BioSciences Reports Second Quarter 2008 Financial Results
10. Sangamo BioSciences Announces Second Quarter Conference Call and Webcast
11. Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2009)...mmer grass that tickles your feet or the red Borde... the world around you carries special chemical mar...entists where the molecules that compose a substan...d to them along the way. But doing these analyses ...s have developed a new method to make isotopic ana...
(Date:6/30/2009)...0 Zimmer Holdings, Inc. ...d quarter 2009 sales and earnings conference call ...ay, July 23, 2009, at 8:00 a.m. Eastern Time. A n...e made available at 7:00 a.m. the morning of the c...be accessed via Zimmer,s Investor Relations websit...
(Date:6/30/2009)...EWTON, Mass., June 30 Microfluidic...rnational Corporation (OTC Bulletin Board: MFLU), ...ategic alliance to help biopharmaceutical companie...nology and formulation methods available to develo... Ingredients (APIs). , , Particle Sciences is a...
(Date:6/30/2009)...une 30 Hospira, Inc. (NY... medication delivery company, today announced agre...ons and gravity I.V. equipment, and a renewal of i...edAssets agreements are effective as of June 1, 20...2009, for infusion devices. These new agreements r...
Breaking Biology Technology:Stanford researchers find a quicker, cheaper way to sort isotopes 2Stanford researchers find a quicker, cheaper way to sort isotopes 3Particle Sciences and Microfluidics Collaborate to Share Formulation and Nanotechnology Expertise for Pharmaceutical Drug Product Development, Analysis and Commercialization 2Particle Sciences and Microfluidics Collaborate to Share Formulation and Nanotechnology Expertise for Pharmaceutical Drug Product Development, Analysis and Commercialization 3Hospira Announces New Contract With MedAssets for Intravenous Solutions, Renewal of Infusion Devices Agreement 2
...sed the word boundaryless to describe his vision f...the hierarchical, get-seven-signatures-before-buyi...Es ability to move nimbly into markets, execute qu...c developers would do well to tear a note from Wel...ing in boundaryless fashion. Its time economic dev...
....-Beware calling the next strange idea you hear st...t millionaire next door. , ,A panel of experience... Wisconsin Entrepreneurs Conference in Milwaukee l...heir entire working lives, and they encouraged the... as a way of life and help each other fulfill thos...
...o talk about the long road from recession to recov...d not rebound quickly. This wasnt going to be cou...les behind us, its beginning to look like the race...bad news is all but over. Jobless claims are falli... weeks, a handful of venture firms have put togeth...
...ck Kennedy has focused his professional career on ... in the telecom and entertainment fields. Currentl... of the Sony Digital Networks Division , an a...iN, SoapCity, Screenblast, the company,s mobile co...vanced platform service units. Mr. Kennedy also se...
Other Biology Technology:Lowering the fear factor for entrepreneurs, intra-preneurs 2Lowering the fear factor for entrepreneurs, intra-preneurs 3The End is Near or Is It? 2The End is Near or Is It? 3The End is Near or Is It? 4WTN exclusive interview with Patrick Kennedy, exec. VP, Sony Pictures Digital 2WTN exclusive interview with Patrick Kennedy, exec. VP, Sony Pictures Digital 3WTN exclusive interview with Patrick Kennedy, exec. VP, Sony Pictures Digital 4
(Date:6/30/2009)...ulated that food consumption in birds and mammals ...ould eat as much as they could while food was plen...allow them to. However, recent research has shown...eaches a limit, even in animals with high nutrient... the Research Institute of Wildlife Ecology in Vie...
(Date:6/30/2009)...iotechnology to help address significant social an...h" by the rigid opposition of some groups and regu... of genetically modified trees, scientists argue i...a regulatory environment that considers geneticall...is, and is focused on the end product rather than ...
(Date:6/30/2009)...g to a new study 1 which shows that like humans, ...een ,good, and ,bad, paintings. According to Profe...n, pigeons use both color and pattern cues to judg...ell as their texture. Professor Watanabe,s work h...l, Animal Cognition . , The concept of beauty i...
(Date:6/30/2009)...important first step toward the development of new...cterium tuberculosis (TB) infection. In their rep... Journal of Leukocyte Biology ( http://www.jleuk...e cellular and molecular mechanisms used by the lu...cial for researchers developing treatments to help...
Breaking Biology News(10 mins):Key to evolutionary fitness: Cut the calories 2Anti-biotech groups obstruct forest biotechnology 2Anti-biotech groups obstruct forest biotechnology 3A bird's eye view of art 2Harvard scientists solve mystery about why HIV patients are more susceptible to TB infection 2Idenix Pharmaceuticals to Present at the JP Morgan 26th Annual Healthcare Conference 8608 1MedImmune Expands Scientific and Engineering Leadership 8603 1MedImmune Expands Scientific and Engineering Leadership 8603 2MedImmune Expands Scientific and Engineering Leadership 8603 3MedImmune Expands Scientific and Engineering Leadership 8603 4MedImmune Expands Scientific and Engineering Leadership 8603 5Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008 2329 1Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008 2329 2Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008 2329 3Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008 2329 4Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008 2329 5Mental health linked to amputation risk in diabetic veterans 8601 1Mental health linked to amputation risk in diabetic veterans 8601 2
...an unusual shape called Z-DNA, it can lead to the ...s such as leukemia and lymphoma, according to a st.... Anderson Cancer Center. , The study, issued in ...of the National Academy of Sciences, demonstrates ...ause DNA breaks in mammalian cells. , Interestin...
... antibiotic use in food-producing animals may be l... found in its citizens, according to an article in... now available online. , Campylobacter jejuni is ...industrialized countries. Drug resistance can make... to treat, and can result in longer bouts of diarr...
...ules bind to specific sites on the neurotoxin prot...e toxin,s effect. In some cases, the study noted, ...uch as fourteen-fold, the greatest increase in act...study, a two-fold activation of a protease was ref...s are enzymes that act as cellular catalysts, brea...
...sts at two universities may lead to new directions...covered that a genetic switch involved in growth a...o prevent normal cells from becoming cancerous. , ... Current Biology. Experiments were carried out by ...ientist working in the laboratories of Joel H. Rot...
Other Biology News:When good DNA goes bad 2When good DNA goes bad 3Less antibiotic use in food animals leads to less drug resistance in people, study shows 2Scientists develop a way to make the deadliest toxin known even more toxic 2Scientists discover a genetic switch that links animal growth and cancer 2
TUNEL Apoptosis Detection Kit
The NOS assay kit measures NOS activity by monitoring the conversion of radiolabeled arginine to citrulline. This assay is simple, sensitive, and specific for NOS activity and can be used with both c
HiTrap NHS-activated HP, 1 x 5 ml. Category: Chromatography Systems & Accessories, Systems.
Mouse Axl MAb (Clone 175128)
Biology Products: